Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Robert Q. Le, Donna Przepiorka, Haiyan Chen, Yuan Li Shen, E. Dianne Pulte, Kelly Norsworthy, Marc R. Theoret, R. Angelo De Claro

Blood (2024) 144 (2): 206–215.

https://doi.org/10.1182/blood.2023023313

Published: 2024

Includes: Supplemental data

Journal Articles

Analysis of Immune-Related Adverse Reactions in Patients with Classical Hodgkin Lymphoma (cHL) on Programmed Death-1 (PD-1) Inhibitor Therapy

Michael Brave, Jinzhong Liu, PhD, Donna Przepiorka, MDPhD, Gideon Blumenthal, MD, Barry W. Miller, MS, CNP

Blood (2018) 132 (Supplement 1): 1652.

https://doi.org/10.1182/blood-2018-99-114101

Published: 2018

Journal Articles

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Kelly J. Norsworthy, MD, Flora Mulkey, MS, Ashley F. Ward, MD, Donna Przepiorka, MDPhD, Albert B. Deisseroth, MD PhD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2018) 132 (Supplement 1): 288.

https://doi.org/10.1182/blood-2018-99-117426

Published: 2018

Journal Articles

Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score

Steven T Bird, PhD PharmD, Natasha Flowers, BA, Fang Tian, PhD MHS, MPH, Donna Przepiorka, MD PhD, Tae Hyun Jung, PhD, Rongrong Wang, MPH, Zebulin Kessler, BS, Corinne Woods, RPh, MPH, Bo Kim, BA, Barry W. Miller, MS, CNP, Michael Wernecke, BA, Stephen McKean, PhD, Clara Kim, PhD, Kate Gelperin, MD MPH, Jeffrey A Kelman, MD MMSc, David J Graham, MD MPH

Blood (2018) 132 (Supplement 1): 2889.

https://doi.org/10.1182/blood-2018-99-116498

Published: 2018

Journal Articles

Developing a Genomics Model to Predict Failure of Isocitrate Dehydrogenase (IDH) Inhibitors for Treatment of Patients with IDH1- or IDH2-Mutated Acute Myeloid Leukemia

Tigran Ghazanchyan, MS, Dickran Kazandjian, MD, Donna Przepiorka, MD PhD, Kelly J. Norsworthy, MD, Emma Scott, PhD, Luis Santana-Quintero, PhD, Svetlana Petrovskaya, PhD, Yong Zhang, PhD, Amy Rosenberg, MD, Ashutosh Rao, PhD, Richard Pazdur, MD, Ann T. Farrell, MD, Julia A. Beaver, MD, Vahan Simonyan, PhD

Blood (2018) 132 (Supplement 1): 2815.

https://doi.org/10.1182/blood-2018-99-116870

Published: 2018

Journal Articles

Exploration of PRO-CTCAE Data Used for Exposure-Response Relationships in an Oncology Clinical Trial

Huiming Xia, PhD MS, Jeanne Zirkelbach Fourie, PhD, Brian Booth, PhD, Yaning Wang, PhD M.A., Mallorie H. Fiero, PhD, Donna Przepiorka, MD PhD, Paul Kluetz, MD

Blood (2017) 130 (Supplement 1): 5670.

https://doi.org/10.1182/blood.V130.Suppl_1.5670.5670

Published: 2017

Journal Articles

Oral Voriconazole for Empiric Antifungal Treatment in Uncomplicated Febrile Neutropenic Patients.

Kara Keasler, PharmD, Joyce Broyles, Pharm.D., Brian McClune, DO, Francis Buadi, MD, Donna Przepiorka, MD, PhD

Blood (2006) 108 (11): 5494.

https://doi.org/10.1182/blood.V108.11.5494.5494

Published: 2006

Journal Articles

Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma.

Gregory Franz, MD, Brian McClune, DO, Francis Buadi, MD, William Walsh, MD, Frank White, MD, Donna Przepiorka, MD, PhD

Blood (2006) 108 (11): 5329.

https://doi.org/10.1182/blood.V108.11.5329.5329

Published: 2006

Journal Articles

Intrathecal Liposomal Cytarabine (Depocyt) Is Safe and Effective for Prevention of Meningeal Disease in Patients with Acute Lymphoblastic Leukemia and High-Grade Lymphoma Treated with the HyperCVAD Regimen.

Brian McClune, DO, Francis Buadi, MD, Naveed Aslam, MD, Donna Przepiorka, MD, PhD

Blood (2005) 106 (11): 4594.

https://doi.org/10.1182/blood.V106.11.4594.4594

Published: 2005

Journal Articles

Natural History of Relapse after Autologous Stem Cell Transplantation for Multiple Myeloma.

Brian McClune, DO, Francis Buadi, MD, Furhan Yunus, MD, Sohail Minhas, MD, William Walsh, MD, Donna Przepiorka, MD, PhD

Blood (2005) 106 (11): 5511.

https://doi.org/10.1182/blood.V106.11.5511.5511

Published: 2005

Journal Articles

The Addition of Rituximab to Standard High Dose BEAM Chemotherapy for Autologous Stem Cell Transplant in Patients with Lymphoma Does Have a Significant Effect on Engraftment.

Francis K. Buadi, MD, Brian McClune, MD, Yoriann S. Hull, Furhan Yunus, MD, Sohail Minhas, MD, Donna Przepiorka, MD, PhD

Blood (2005) 106 (11): 5325.

https://doi.org/10.1182/blood.V106.11.5325.5325

Published: 2005

Journal Articles

African Americans and Caucasians with Myeloma Have Similar Outcomes in the Current Era: A Tumor Registry Study.

Brian McClune, MD, Birendra Kumar, MD, Francis Buadi, MD, Robin Womeodu, MD, Kathy Wright, Reed Baskin, MD, Sohail Minhas, MD, Thomas W. Ratliff, MD, Kathleen Spiers, MD, Furhan Yunus, MD, Donna Przepiorka, MD, PhD

Blood (2004) 104 (11): 3134.

https://doi.org/10.1182/blood.V104.11.3134.3134

Published: 2004

Journal Articles

Race Has No Effect on Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.

Francis Buadi, MD, Brian McClune, MD, Yoriann Moore, Robin Womeodu, MD, Furhan Yunus, MD, William Walsh, MD, Sohail Minhas, MD, Donna Przepiorka, MD

Blood (2004) 104 (11): 5242.

https://doi.org/10.1182/blood.V104.11.5242.5242

Published: 2004

Journal Articles

Babies helping babies with leukemia

Donna Przepiorka

Blood (2003) 102 (13): 4249.

https://doi.org/10.1182/blood-2003-09-3332

Published: 2003

Journal Articles

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

Donna Przepiorka, Paolo Anderlini, Rima Saliba, Karen Cleary, Rakesh Mehra, Issa Khouri, Yang O. Huh, Sergio Giralt, Ira Braunschweig, Koen van Besien, Richard Champlin

Blood (2001) 98 (6): 1695–1700.

https://doi.org/10.1182/blood.V98.6.1695

Published: 2001

Journal Articles

Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen–matched related donors

Donna Przepiorka, Terry L. Smith, Jody Folloder, Paolo Anderlini, Ka-Wah Chan, Martin Körbling, Benjamin Lichtiger, Frank Norfleet, Richard Champlin

Blood (2001) 97 (11): 3405–3410.

https://doi.org/10.1182/blood.V97.11.3405

Published: 2001

Journal Articles

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Blood (2001) 97 (3): 631–637.

https://doi.org/10.1182/blood.V97.3.631

Published: 2001

Journal Articles

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Richard A. Nash, Joseph H. Antin, Chatchada Karanes, Joseph W. Fay, Belinda R. Avalos, Andrew M. Yeager, Donna Przepiorka, Stella Davies, Finn B. Petersen, Pamela Bartels, Donald Buell, William Fitzsimmons, Claudio Anasetti, Rainer Storb, Voravit Ratanatharathorn

Blood (2000) 96 (6): 2062–2068.

https://doi.org/10.1182/blood.V96.6.2062

Published: 2000

Journal Articles

Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

Donna Przepiorka, Terry L. Smith, Jody Folloder, Issa Khouri, Naoto T. Ueno, Rakesh Mehra, Martin Körbling, Yang O. Huh, Sergio Giralt, James Gajewski, Michele Donato, Karen Cleary, David Claxton, Ira Braunschweig, Koen van Besien, Borje S. Andersson, Paolo Anderlini, Richard Champlin

Blood (1999) 94 (4): 1465–1470.

https://doi.org/10.1182/blood.V94.4.1465

Published: 1999

Journal Articles

Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

Philippe Guardiola, Jeanne E. Anderson, Giuseppe Bandini, Francisco Cervantes, Volker Runde, William Arcese, Andrea Bacigalupo, Donna Przepiorka, Margaret R. O’Donnell, Paola Polchi, Agnès Buzyn, Laurent Sutton, Dominique Cazals-Hatem, George Sale, Theo de Witte, H. Joachim Deeg, Eliane Gluckman

Blood (1999) 93 (9): 2831–2838.

https://doi.org/10.1182/blood.V93.9.2831

Published: 1999

NARROW

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Analysis of Immune-Related Adverse Reactions in Patients with Classical Hodgkin Lymphoma (cHL) on Programmed Death-1 (PD-1) Inhibitor Therapy

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score

Developing a Genomics Model to Predict Failure of Isocitrate Dehydrogenase (IDH) Inhibitors for Treatment of Patients with IDH1- or IDH2-Mutated Acute Myeloid Leukemia

Exploration of PRO-CTCAE Data Used for Exposure-Response Relationships in an Oncology Clinical Trial

Oral Voriconazole for Empiric Antifungal Treatment in Uncomplicated Febrile Neutropenic Patients.

Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma.

Intrathecal Liposomal Cytarabine (Depocyt) Is Safe and Effective for Prevention of Meningeal Disease in Patients with Acute Lymphoblastic Leukemia and High-Grade Lymphoma Treated with the HyperCVAD Regimen.

Natural History of Relapse after Autologous Stem Cell Transplantation for Multiple Myeloma.

The Addition of Rituximab to Standard High Dose BEAM Chemotherapy for Autologous Stem Cell Transplant in Patients with Lymphoma Does Have a Significant Effect on Engraftment.

African Americans and Caucasians with Myeloma Have Similar Outcomes in the Current Era: A Tumor Registry Study.

Race Has No Effect on Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.

Babies helping babies with leukemia

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen–matched related donors

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation

Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only